Related Experiment Video
Updated: Jun 22, 2026

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
[Effect of doxycycline on the development of pulmonary hypertension induced by four methods in rats]
1Department of Pediatric Cardiology, West China Second Hospital, Sichuan University, Chengdu 610041, China.
Objective:
Based on establishment of four rat models of experimental pulmonary hypertension (PH), the authors examined the inhibition of matrix metalloproteinases (MMPs) by doxycycline and its effect on the development of PH and associated pulmonary vascular remodeling.
Method:
Healthy male Sprague-Dawley rats (weight 350 g to 400 g) were randomly divided into nine groups: Normal control group (N), four model groups (H, M, P, PM) and their corresponding drug intervention groups (HD, MD, PD, PMD) in which doxycycline was given by gavage at a 20 mg/kg daily dosage. On day 28 (day 35 for PM and PMD models), the animals were catheterized to record mean pulmonary arterial pressure (mPAP) and then sacrificed. Fulton Index [RV/(LV + S)] was measured immediately. Morphometric parameters, including percent vascular wall thickness and muscularization of non-muscularized peripheral pulmonary arterioles were determined microscopically. The activity of MMPs was measured by gelatin zymography in the lung tissue.
Results:
(1) Rats in all model groups (H, M, P, PM) developed significant pulmonary arterial hypertension and right ventricular hypertrophy in comparison with their corresponding drug intervention groups (HD, MD, PD, PMD) and normal control group (N) (P < 0.01). For example, mPAP (mm Hg)(1 mm Hg = 0.133 kPa):N: 18.10 +/- 1.45, H: 27.20 +/- 1.55, HD: 23.90 +/- 2.13; Fulton Inedx(%):N: 23.41 +/- 1.84, H: 34.44 +/- 2.70, HD: 27.55 +/- 2.45. (2) The percent vascular wall thickness (WT%) and percentage of muscularization of non-muscular pulmonary arterioles were significantly increased in all model groups compared with drug intervention groups and normal group (P < 0.01). For example, WT%:N: 10.90 +/- 3.11, H:41.41 +/- 5.21, HD: 17.73 +/- 3.12; Muscularization(%):N: 13.83 +/- 3.72, H: 44.93 +/- 2.43, HD: 29.89 +/- 4.45. (3) The activity of MMPs was inhibited by doxycycline effectively as assessed by gelatin zymography (P < 0.01). For example, the activity of MMP2 (A x 10(3)):N: 1.43 +/- 0.24, H: 3.58 +/- 0.28, HD: 2.29 +/- 0.31.
Conclusion:
Doxycycline attenuated PH and associated pulmonary vascular remodeling in all rat PH models. The study suggests that high expression and enhanced activity of MMPs may play a brutial role in the development of PH. Such phenomenon seems to be common in a variety of PH models of different etiology.
Insights
Doxycycline treatment effectively reduced pulmonary hypertension (PH) and pulmonary vascular remodeling in rat models. This suggests matrix metalloproteinases (MMPs) play a key role in PH development across various etiologies.
Area of Science:
- Cardiovascular Research
- Pulmonary Medicine
- Pharmacology
Context:
- Pulmonary hypertension (PH) is a severe condition characterized by elevated pressure in the pulmonary arteries.
- Pulmonary vascular remodeling, including vascular wall thickening and increased muscularization, contributes significantly to PH.
- Matrix metalloproteinases (MMPs) are implicated in tissue remodeling, but their specific role in PH development requires further elucidation.
Purpose:
- To investigate the inhibitory effect of doxycycline on matrix metalloproteinases (MMPs).
- To evaluate the impact of doxycycline on the development of experimental pulmonary hypertension (PH) and associated pulmonary vascular remodeling in rat models.
- To explore the role of MMPs in various etiologies of PH.
Summary:
- Four rat models of experimental PH were established and treated with doxycycline (20 mg/kg daily).
- Doxycycline administration significantly attenuated mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy (Fulton Index), vascular wall thickness, and smooth muscle proliferation in pulmonary arterioles.
- Gelatin zymography confirmed that doxycycline effectively inhibited MMP activity, including MMP2, in lung tissues.
Impact:
- Doxycycline demonstrated a therapeutic effect in mitigating PH and pulmonary vascular remodeling across different experimental models.
- The findings highlight the crucial role of high expression and enhanced activity of MMPs in the pathogenesis of PH.
- This study provides evidence for a common mechanism underlying PH development, irrespective of the initial etiological factors, suggesting potential therapeutic targets.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

